
Xeris Biopharma Holdings Inc
NASDAQ:XERS

Intrinsic Value
The intrinsic value of one
XERS
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 4.88 USD,
Xeris Biopharma Holdings Inc
is
hidden
.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Xeris Biopharma Holdings Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Xeris Biopharma Holdings Inc
Balance Sheet Decomposition
Xeris Biopharma Holdings Inc
Current Assets | 167.7m |
Cash & Short-Term Investments | 71.6m |
Receivables | 40.4m |
Other Current Assets | 55.6m |
Non-Current Assets | 155.4m |
PP&E | 28.2m |
Intangibles | 121.8m |
Other Non-Current Assets | 5.4m |
Free Cash Flow Analysis
Xeris Biopharma Holdings Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Xeris Biopharma Holdings Inc
Revenue
|
203.1m
USD
|
Cost of Revenue
|
-36.8m
USD
|
Gross Profit
|
166.2m
USD
|
Operating Expenses
|
-199.9m
USD
|
Operating Income
|
-33.6m
USD
|
Other Expenses
|
-21.2m
USD
|
Net Income
|
-54.8m
USD
|
XERS Profitability Score
Profitability Due Diligence
Xeris Biopharma Holdings Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Score
Xeris Biopharma Holdings Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.
XERS Solvency Score
Solvency Due Diligence
Xeris Biopharma Holdings Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Score
Xeris Biopharma Holdings Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
XERS Price Targets Summary
Xeris Biopharma Holdings Inc
According to Wall Street analysts, the average 1-year price target for
XERS
is 6.38 USD
with a low forecast of 4.04 USD and a high forecast of 8.4 USD.
Dividends
Current shareholder yield for XERS is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
XERS
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 4.88 USD,
Xeris Biopharma Holdings Inc
is
hidden
.